Testosterone pellets vs injections differ most in how long the treatment remains fixed. Pellets stay under the skin through a labeled three-to-six-month interval, so the delivered testosterone cannot be changed between implantations. Testosterone cypionate injections follow a prescribed cycle, giving your physician an earlier opportunity to adjust treatment after reviewing your symptoms and labs. Both routes can raise testosterone, but the available evidence does not establish one as universally more effective.1-6
Route Fundamentals in Prescribed TRT
Testosterone pellets and testosterone cypionate injections deliver the same hormone through different formulations. The route changes how testosterone enters circulation, how concentrations move over time, and when your physician can make an adjustment.
TESTOPEL consists of testosterone pellets implanted under the skin. The federal prescribing information describes TESTOPEL as replacement therapy for androgen-deficient males and lists an interval of every three to six months.1 Implantation requires a brief office procedure.
DEPO-TESTOSTERONE is an injectable form of testosterone cypionate. Its formulation contains testosterone cypionate in a cottonseed-oil vehicle with benzyl benzoate and benzyl alcohol.2 Your prescriber sets the injection schedule and reviews the response over repeated cycles.
Neither label tells your physician which route fits you better. That decision depends on your baseline labs, symptoms, response to treatment, and tolerance for each route.
Concentration Patterns in One Table
The main clinical difference is the opportunity to adjust testosterone exposure. Pellets remain in place for months, while an injection prescription can be revised at a future scheduled dose.
| Route | Formulation Basis From the Label | Labeled Dosing Interval | Concentration Pattern Over the Interval |
|---|---|---|---|
| Testosterone pellets | Testosterone pellets implanted subcutaneously.1 | Every three to six months under the TESTOPEL label.1 | Testosterone generally rises after implantation and then declines over several months. Peak level and decay vary with pellet count and body mass index (BMI), which is a measure of weight relative to height.3,4 |
| Testosterone cypionate injection | Testosterone cypionate in cottonseed oil with benzyl benzoate and benzyl alcohol.2 | The prescriber sets the injection cycle. Numeric injection guidance is not reproduced here. | Concentrations follow a peak-and-trough pattern. The size and timing of those changes depend on the formulation and prescribed schedule.5 |
| Clinical comparison | Neither formulation is universally superior. | Pellets remain fixed through a longer interval. Injection decisions recur sooner. | Pellets reduce the number of administration events. Injections give your physician an earlier point to adjust treatment when symptoms or labs call for a change. |
A longer interval can reduce how often testosterone must be administered. It also reduces the opportunities to respond quickly if your follow-up results fall outside the intended range.
An injection schedule requires repeated administration. The same schedule gives your physician more frequent decision points. Convenience and adjustability move in opposite directions in this comparison.
Pellet Levels Over the Implantation Interval
Pellet testosterone levels rise and decline over several months. A pharmacotherapy review reported that implantation increased total testosterone into the therapeutic range at about one month and sustained therapeutic levels for four to six months.3 That finding describes the general pattern across the evidence reviewed. It does not mean every person reaches the same concentration or follows the same timeline.
A separate cohort study found that testosterone and free-testosterone peaks varied with the number of pellets implanted.4 Free testosterone is the portion that is not tightly bound to proteins and is more readily available to tissues. Men with a BMI of 25 kg/m² or higher had lower peaks and slower decay than men with a lower BMI in the pellet groups studied.4
The study did not compare pellets directly with injections. It also did not establish a best pellet count for every person. It showed that pellet exposure depends partly on how many pellets are placed and on body composition.
Those variables are set at implantation. If your symptoms or labs call for a different exposure later, the pellets cannot be revised while they remain under the skin. Your physician must account for that fixed interval before treatment starts.
Injection Peaks and Troughs
Testosterone injections create recurring peaks and troughs in blood concentration. A pharmacokinetic review found that the size, frequency, and duration of those changes vary across testosterone formulations and routes.5
The same review concluded that no testosterone therapy exactly reproduces the normal daily rhythm seen in younger men.5 Three of the review’s authors were employees of a testosterone-therapy manufacturer. The paper remains useful for describing pharmacokinetic patterns, but that relationship belongs in your reading of the evidence.
The peak-and-trough pattern does not prove that injections are inferior to pellets. It tells your physician when symptoms and laboratory measurements need context. A testosterone result taken near a peak can look different from one taken later in the prescribed cycle.
Injections also allow treatment to be reconsidered at the next scheduled dose. If your labs or symptoms move in the wrong direction, your prescriber has an earlier opportunity to revise the plan.
Factors in a Prescriber’s Route Decision
A physician weighs more than convenience when comparing testosterone pellets vs injections. The decision usually starts with how much control the treatment plan may require between follow-up visits.
Opportunity for Adjustment
Pellets remain implanted through the treatment interval. Their concentration pattern can vary with pellet count and body composition, but those inputs cannot be changed after implantation.4
Injections create a recurring point for clinical review. Your physician can use your response to the current cycle when setting a future prescription. That flexibility may carry more weight when your symptoms or laboratory values are changing.
Procedure and Administration
Pellets require an office implantation procedure. You then go for months without another administration event, although clinical review and laboratory testing continue.
Injections avoid implantation but require repeated administration under a prescribed plan. If you dislike either procedures or recurring injections, tell your physician before the route is selected. A route that you cannot follow consistently is difficult to evaluate.
Laboratory Patterns
One testosterone value rarely settles a route decision. Your physician needs to know when the sample was collected relative to an injection or pellet implantation.
The broader pattern also matters. Symptoms, total testosterone, free testosterone, and treatment-related laboratory changes need to be read together. A value can fall inside a laboratory reference range while the full pattern still warrants review.
Erythrocytosis Risk
Erythrocytosis is an increase in red blood cell concentration. A literature review found that short-acting injectable testosterone formulations had the highest associated incidence of erythrocytosis among the testosterone formulations it evaluated.6
That finding does not predict what will happen in your case. It does give your physician a reason to monitor the relevant blood counts and interpret changes in the context of your formulation. Detailed management of elevated hematocrit belongs in the guide to hematocrit on TRT.
Your Likely Follow-Through
The prescribed route has to fit your willingness to return for a procedure or follow a recurring injection schedule. This is a practical part of treatment because missed administrations and delayed follow-up make the response harder to interpret.
This comparison cannot decide treatment for you if you do not have baseline labs and a clinical diagnosis. The testosterone therapy overview explains the broader evaluation that comes before a route decision.
Limits of the Available Comparison
The available evidence describes how each route behaves, but it does not include a randomized head-to-head trial proving that pellets or injections produce better overall outcomes. The pellet cohort studied variation by pellet count and BMI.4 The pharmacokinetic reviews summarized concentration patterns across existing studies.3,5,6
The sources also do not establish a universal symptom response. A smoother-looking concentration curve does not guarantee better energy, sexual function, mood, or body composition for you. An adjustable route does not guarantee that an adjustment will be necessary.
Your physician can make a firmer route decision after seeing how your symptoms align with your baseline results. Follow-up testing then shows whether the prescribed plan is producing the intended pattern.
Related TRT Route and Cost Questions
Topical cream or gel is another testosterone route, but it has different absorption and daily-use considerations. The testosterone injections vs cream comparison covers that choice, and the direct testosterone cream vs pellets comparison covers cream against the pellet route on this page, without expanding this page into a three-route table.
Testosterone cypionate also belongs to a larger group of injectable formulations. The testosterone cypionate guide covers ester-specific questions.
Cost depends on the medication, implantation procedure, laboratory testing, and clinical monitoring included in the plan. The TRT cost guide explains those separate line items. A headline medication price does not show the complete cost of monitored treatment.
The Opt Take on Testosterone Pellets vs Injections
At Opt Health, a physician reviews a panel of 55 or more biomarkers, compares the results with your symptoms and current medications, and reassesses the plan with repeat labs every three to four months. The route is one part of that process.
Pellets can reduce administration events, but their exposure remains fixed between implantations. Injections require recurring administration and allow an earlier adjustment point. Your baseline is followed by interpretation, treatment, retesting, and adjustment. That loop gives your physician enough information to judge whether the route continues to fit you.
Get started: Begin with Opt Health, where a physician reads your labs, builds your plan, and adjusts it over the loop.
Frequently Asked Questions
Testosterone pellets require a subcutaneous implantation procedure and cannot be adjusted after they are placed. Their testosterone peak and decay pattern can also vary with pellet count and BMI.4
The longer interval may appeal to you if you want fewer administration events. You must also accept that your physician cannot revise the implanted amount if early symptoms or labs suggest that exposure should change. Follow-up still matters even when administration is less frequent.
A named individual’s reported TRT protocol is not evidence for what you should use. The closed sources for this comparison do not establish Joe Rogan’s regimen, and a public statement would not provide the clinical information needed to apply it to you.
Your route decision should be based on your diagnosis, baseline labs, symptoms, medical history, and follow-up response. The product labels and pharmacokinetic evidence support that clinical comparison.
The available sources do not identify a universally most effective testosterone form. Pellets and injections use different concentration patterns and adjustment intervals, while neither route exactly mimics normal daily testosterone secretion.3-5
Your physician can judge effectiveness by comparing your symptoms and laboratory trends over time. The prescribed route must also be practical enough for you to follow consistently.
The TESTOPEL label gives an interval of every three to six months between pellet treatments.1 That interval does not establish a maximum number of years that you can remain on pellet therapy.
Continued treatment requires periodic review of your diagnosis, response, laboratory results, and any treatment-related concerns. Your prescriber decides whether another implantation remains appropriate at each review.
The sources used for this comparison do not provide a list of aftercare restrictions. They establish that TESTOPEL is implanted subcutaneously and that implantation requires a clinical procedure.1
Implantation-site care should come directly from the prescriber who performs the procedure. Contact that clinical team if your written instructions are missing or if you develop a concern at the site.
The sources used here do not establish that testosterone pellets cause weight gain. They address formulation, dosing interval, testosterone concentration patterns, and formulation-related blood changes.
If your weight changes during treatment, your physician can compare the timing with your symptoms, body-composition trend, and follow-up labs. That review is more useful than assigning the change to the pellet without supporting data.
References
- Auxilium Pharmaceuticals / Endo Pharmaceuticals. TESTOPEL (testosterone) pellet: full prescribing information. DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a1741a0b-3d4c-42dc-880d-a06e96cce9ef
- Pharmacia & Upjohn. DEPO-TESTOSTERONE (testosterone cypionate) injection, solution: full prescribing information. DailyMed, National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cfbb53d4-b868-4a28-8436-f9112eb01c39
- Kresch E, Patel M, Lima TFN, Ramasamy R. An update on the available and emerging pharmacotherapy for adults with testosterone deficiency available in the USA. Expert Opin Pharmacother. 2021;22(13):1761-1771. https://pubmed.ncbi.nlm.nih.gov/33866902/
- Pastuszak AW, Mittakanti H, Liu JS, Gomez L, Lipshultz LI, Khera M. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl. 2012;33(5):927-937. https://pubmed.ncbi.nlm.nih.gov/22403285/
- Pastuszak AW, Gittelman M, Tursi JP, et al. Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age. Andrology. 2022;10(2):209-222. https://pubmed.ncbi.nlm.nih.gov/34510812/
- Ohlander SJ, Varghese B, Pastuszak AW. Erythrocytosis following testosterone therapy. Sex Med Rev. 2018;6(1):77-85. https://pubmed.ncbi.nlm.nih.gov/28526632/
This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.
This article is part of our guide to testosterone. See how physician-managed TRT works at Opt Health.
Start Today
Your health, your terms. Discover how personalized care can transform not just the way you feel, but how you live.